Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
29272 | 155 | 55.2 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
348 | 16958 | DNA METHYLATION//EPIGENETICS//HISTONE DEACETYLASE INHIBITOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | METABOLIC MEMORY | Author keyword | 6 | 29% | 12% | 18 |
2 | HYPERGLYCEMIC MEMORY | Author keyword | 2 | 50% | 2% | 3 |
3 | EPIGEN PROFILING IL | Address | 2 | 28% | 3% | 5 |
4 | HYPERHEXOSEMIA | Author keyword | 1 | 100% | 1% | 2 |
5 | SET7 METHYLTRANSFERASE | Author keyword | 1 | 100% | 1% | 2 |
6 | EPIGENET HUMAN HLTH DIS | Address | 1 | 14% | 6% | 9 |
7 | DR WILLIAM M OLL PODIATR MED | Address | 1 | 13% | 3% | 5 |
8 | BASIC MED POSTDOCTORAL STUDIES | Address | 1 | 50% | 1% | 1 |
9 | CELLULAR MOL DIABET | Address | 1 | 50% | 1% | 1 |
10 | ENDOCRINOL DIABETEOL | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | METABOLIC MEMORY | 7 | 34% | 11% | 17 |
2 | GOOD GLYCEMIC CONTROL | 7 | 38% | 10% | 15 |
3 | VASCULAR HYPERGLYCEMIC MEMORY | 2 | 50% | 2% | 3 |
4 | VASOACTIVE FACTORS | 2 | 31% | 3% | 5 |
5 | I DIABETIC NEPHROPATHY | 1 | 38% | 2% | 3 |
6 | HISTONE METHYLATION PATTERNS | 1 | 100% | 1% | 2 |
7 | FIBRONECTIN SYNTHESIS | 1 | 11% | 6% | 10 |
8 | INTENSIFIED MULTIFACTORIAL INTERVENTION | 1 | 50% | 1% | 1 |
9 | HYPERGLYCEMIC MEMORY | 0 | 33% | 1% | 1 |
10 | INFLAMMATORY PHENOTYPE | 0 | 33% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Epigenetic mechanisms in diabetic complications and metabolic memory | 2015 | 7 | 94 | 26% |
Glycemic memory | 2012 | 15 | 49 | 27% |
Role of epigenetic mechanisms in the development of chronic complications of diabetes | 2014 | 6 | 89 | 20% |
Epigenetic Modifications in the Pathogenesis of Diabetic Nephropathy | 2013 | 11 | 91 | 20% |
The role of epigenetics in the pathology of diabetic complications | 2010 | 86 | 137 | 14% |
Epigenetic signatures and vascular risk in type 2 diabetes: A clinical perspective | 2013 | 10 | 68 | 19% |
Oxidative-stress-induced epigenetic changes in chronic diabetic complications | 2013 | 10 | 84 | 15% |
Epigenetic mechanisms in diabetic vascular complications | 2011 | 50 | 146 | 12% |
Epigenetics Mechanisms and Implications for Diabetic Complications | 2010 | 61 | 82 | 11% |
Epigenetic phenomena linked to diabetic complications | 2010 | 58 | 73 | 11% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EPIGEN PROFILING IL | 2 | 28% | 3.2% | 5 |
2 | EPIGENET HUMAN HLTH DIS | 1 | 14% | 5.8% | 9 |
3 | DR WILLIAM M OLL PODIATR MED | 1 | 13% | 3.2% | 5 |
4 | BASIC MED POSTDOCTORAL STUDIES | 1 | 50% | 0.6% | 1 |
5 | CELLULAR MOL DIABET | 1 | 50% | 0.6% | 1 |
6 | ENDOCRINOL DIABETEOL | 1 | 50% | 0.6% | 1 |
7 | KATEDRA CHEM BIOCHEM | 1 | 50% | 0.6% | 1 |
8 | LONDON HLTH SC | 1 | 50% | 0.6% | 1 |
9 | INT DIABET COMPLICAT | 1 | 29% | 1.3% | 2 |
10 | DIABET COMPLICAT METAB | 0 | 33% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000241167 | MOL DIABET//GDD GED TOXICOL//HARVARD PROGRAM THER EUT SCI |
2 | 0.0000221552 | APOL1//APOLIPOPROTEIN L1//APOLIPOPROTEIN L |
3 | 0.0000185146 | EPIGENETIC EPIDEMIOLOGY//EWAS//EPIGENETICS |
4 | 0.0000178706 | DIABETIC RETINOPATHY//K GE EYE//PENN STATE RETINA GRP |
5 | 0.0000141553 | RUBOXISTAURIN//PENN MOL STUDIES KIDNEY DIS//BEETHAM EYE OPHTHALMOL |
6 | 0.0000111271 | HISTONE DEMETHYLASE//HISTONE DEMETHYLATION//LSD1 |
7 | 0.0000102550 | INTERMITTENT GLUCOSE//POSTPRANDIAL HYPERGLYCEMIA//GLYCEMIC VARIABILITY |
8 | 0.0000097710 | MEF2C//MEF2//MEF2D |
9 | 0.0000085436 | TRAUMA EMERGENCY SURG SURG CRIT CAREMASSAC//HUNAN MED EPIGEN//TOLERANCE BREAKDOWN |
10 | 0.0000080402 | ERK5//MEK5//EXTRACELLULAR SIGNAL REGULATED KINASE 5 ERK5 |